Marc Arbyn

Active 2000–2026

175
Papers
37,877
Citations
91
h-index
170
i10-index

Citations

Citations per year for Marc Arbyn1966: 3 citations1977: 1 citations1983: 1 citations1995: 5 citations2003: 1 citations2004: 2 citations2005: 11 citations2006: 26 citations2007: 55 citations2008: 96 citations2009: 146 citations2010: 131 citations2011: 151 citations2012: 212 citations2013: 142 citations2014: 167 citations2015: 262 citations2016: 211 citations2017: 239 citations2018: 260 citations2019: 946 citations2020: 1,355 citations2021: 1,444 citations2022: 1,244 citations2023: 885 citations2024: 1,623 citations2025: 723 citations2026: 24 citations1967–1976: no citations, so these years are not shown1978–1982: no citations, so these years are not shown1984–1994: no citations, so these years are not shown1996–2002: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,852 citing papers, 15% of this breakdownChina: 1,254 citing papers, 10.1% of this breakdownUnited Kingdom: 985 citing papers, 8% of this breakdownItaly: 469 citing papers, 3.8% of this breakdownFrance: 441 citing papers, 3.6% of this breakdownCanada: 431 citing papers, 3.5% of this breakdownAustralia: 409 citing papers, 3.3% of this breakdownGermany: 402 citing papers, 3.2% of this breakdownNetherlands: 378 citing papers, 3.1% of this breakdownIndia: 359 citing papers, 2.9% of this breakdownBelgium: 318 citing papers, 2.6% of this breakdownSpain: 317 citing papers, 2.6% of this breakdown
0%15%Other 38.3%

Fields

  • Medicine79.1%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Immunology and Microbiology2.4%
  • Computer Science2.3%
  • Psychology1.5%
  • Engineering1%
  • Other5%

Topics

  • Cervical Cancer and HPV Research17.8%
  • Endometrial and Cervical Cancer Treatments5.6%
  • Global Cancer Incidence and Screening5.5%
  • Head and Neck Cancer Studies4%
  • Reproductive tract infections research3.9%
  • Genital Health and Disease2.1%
  • Other61.1%

Coauthors

All papers

Open in search
  1. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

    Authors: , , , , , , - The Lancet Global Health 2019 cited by 4,135

  2. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

    Authors: , , , , , , , , , - The Lancet Global Health 2022 cited by 1,529

  3. Metaprop: a Stata command to perform meta-analysis of binomial data

    Authors: , , - Archives of Public Health 2014 cited by 2,175

  4. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

    Authors: , , , , , , , , , , , , - The Lancet 2013 cited by 1,802

  5. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis

    Authors: , , , , , , , , - The Lancet Global Health 2023 cited by 295

  6. The IARC Perspective on Cervical Cancer Screening

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Béatrice Lauby-Secretan - New England Journal of Medicine 2021 cited by 340

  7. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

    Authors: , , , , - BMJ 2018 cited by 875

  8. Cytology versus HPV testing for cervical cancer screening in the general population

    Authors: , , , , , , , , - Cochrane Database of Systematic Reviews 2017 cited by 499

  9. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2021 cited by 282

  10. Metadta: a Stata command for meta-analysis and meta-regression of diagnostic test accuracy data – a tutorial

    Authors: , - Archives of Public Health 2022 cited by 146

  11. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis

    Authors: , , , , , , , , - The Lancet Oncology 2014 cited by 729

  12. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women

    Authors: , , , , , - JAMA Internal Medicine 2018 cited by 410

  13. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

    Authors: , , , - Cochrane Database of Systematic Reviews 2018 cited by 601

  14. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis

    Authors: , , , , , , , , - BMJ 2016 cited by 481

  15. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening

    Authors: , , , - British Journal of Cancer 2022 cited by 136

  16. Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

    Authors: , , , , , , , , , - Vaccine 2012 cited by 914

  17. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

    Authors: , , , , , , , , , , , - The Lancet Oncology 2014 cited by 676

  18. Meta‐analysis of agreement/concordance statistics in studies comparing self‐ vs clinician‐collected samples for HPV testing in cervical cancer screening

    Authors: , , , , , - International Journal of Cancer 2022 cited by 105

  19. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

    Authors: , , , , , , , , , , , - International Journal of Cancer 2008 cited by 695

  20. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease

    Authors: , , , , , , , , - Cochrane Database of Systematic Reviews 2017 cited by 303

  21. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 96

  22. Triage of HPV positive women in cervical cancer screening

    Authors: , , , - Journal of Clinical Virology 2015 cited by 349

  23. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

    Authors: , , , , , , , , , , , , - British Journal of Cancer 2020 cited by 146

  24. Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature

    Authors: , , , , , , , , , , , , , - Annals of Oncology 2020 cited by 162